More News

02 Apr 2021 Arbutus Biopharma, X-Chem and Proteros biostructures Enter into a Pan-Coronavirus Discovery Research and License Agreement
02 Apr 2021 AbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery Collaboration
02 Apr 2021 Eloxx Pharmaceuticals Acquires Zikani Therapeutics
30 Mar 2021 Leiden University Medical Center and Ixaka enter collaboration to strengthen knowledge of cell therapy candidate REX-001
30 Mar 2021 Novartis expands targeted radioligand therapy pipeline with in-license for compounds targeting Fibroblast Activation Protein (FAP)
30 Mar 2021 BridGene Biosciences Announces Research Collaboration with Takeda to Discover Small Molecule Drugs for "Undruggable" Targets
22 Mar 2021 SemaThera Enters into a Research Collaboration and Exclusive License Agreement with Roche
18 Mar 2021 Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK for the Advancement of Multiple Pre-Phase 2 Programs
17 Mar 2021 Amathus Therapeutics Signs Strategic Collaboration With Merck to Develop Treatments for Neurodegenerative Diseases
17 Mar 2021 Seekyo raises over €650,000 from business angels and Bpifrance
17 Mar 2021 DZNE and Eisai enter into research collaboration agreement aiming for novel drug discovery for neurodegenerative disorders
16 Mar 2021 GBT Expands Sickle Cell Disease Pipeline with Exclusive In-license of Two Novel Small Molecule Programs from Sanofi S.A.
16 Mar 2021 Perception Neuroscience And Otsuka Pharmaceutical Announce Collaboration On Development Of PCN-101 (R-ketamine) In Japan For Treatment-of Depressive Disorders
16 Mar 2021 Boehringer Ingelheim and The Lieber Institute for Brain Development to Collaborate to Develop Centrally Acting COMT Inhibitors for Treatment of Neuropsychiatric Disorders
15 Mar 2021 Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis
11 Mar 2021 Grifols reinforces its innovation strategy after completing the acquisition of GigaGen to boost a novel method to generate a wide range of immunoglobulins
09 Mar 2021 Exelixis Enters into Exclusive License Agreement with WuXi Biologics to Support Further Expansion of its Growing Oncology Biologics Pipeline
09 Mar 2021 Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes
05 Mar 2021 ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics
02 Mar 2021 Mitokinin, Inc., Enters into Purchase Right Agreement with AbbVie
02 Mar 2021 Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
01 Mar 2021 Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies
01 Mar 2021 Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity
01 Mar 2021 HitGen and UPPTHERA Enter Into Drug Discovery Research Collaboration
25 Feb 2021 Merck to Acquire Pandion Therapeutics

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up